Abstract
Setting:100 bed medical ward in referral hospital, Lilongwe, Malawi.Objective:HIV positive patients admitted to hospital often have advanced HIV disease (AHD) and are at risk for mortality. WHO guidelines suggest a package of care for AHD; these are often not implemented, especially in inpatient settings. We describe an implementation model for AHD care, its outcomes in routine care and provide cost estimates.Design:An “AHD care room” was established staffed by HIV counselor, nurse, and clinical officer allowing Provider Initiated Testing and Counseling, diagnostic testing for AHD and ensuring availability of HIV and TB drugs for rapid treatment initiation.Results:In the observation period from January to December 2020, a total of 1549 medical inpatients were tested for HIV (coverage 77.1%); 69 tested positive (yield 4.5%). The total proportion of HIV positive was 32.3% (638 already on ART and 69 newly diagnosed). CD4+ testing was done in 460 medical inpatients (65.1%); 245 (53.2%) were below 200 cells/ml and thus met definition of AHD. A total of 238 received S-CrAg tests; 39 (16.3%) were positive; 62 (28.3%) of 219 U-LAM tests were positive. The cost per identification of HIV positive patient was US$ 110.8; per AHD diagnosis between US$ 17.1 to 78.9; per positive S-CrAg test US$ 18.5 and per positive U-LAM test US$ 17.5.Conclusion:Our model successfully implemented AHD services according to WHO guidelines and provides basic costing data. Similar services could be implemented in other hospitals in LMICs.
Highlights
CD4+ testing was done in 460 medical inpatients (65.1%); 245 (53.2%) were below 200 cells/ml and met definition of advanced HIV disease (AHD)
Similar services could be implemented in other hospitals in Low and middle-income countries (LMICs)
Patients who have been treated longer but on failing antiretroviral therapy (ART) regimen may present to hospitals with AHD
Summary
Many patients are diagnosed HIV positive when already sick and require hospital admission. Others who recently started antiretroviral therapy (ART) are admitted due to opportunistic infections (OI) de-masked by immunereconstitution inflammatory syndrome (IRIS). Patients who have been treated longer but on failing ART regimen may present to hospitals with AHD. HIV patients admitted often have advanced HIV disease (AHD) and carry a high risk of mortality [2, 3]. The most common cause of death of HIV positive inpatients in Low and middle-income countries (LMICs) identified through autopsies is tuberculosis (TB), which is often disseminated and is associated with progressive immunosuppression [4]. The World Health Organization (WHO) published guidelines for the care of AHD in 2017 [6], but implementation requires significant resources.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.